Company / CapEx per Share
BeOne Medicines Ltd. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.13
FY2025
5-year range
$0.13 / $0.41
FY2021-FY2025
Trend
-63.0%
vs FY2024
Sector context
#52 of 192
Health Care
What the data says
At $0.13, BeOne Medicines Ltd.'s capex per share ranks #52 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2017 to $0.41 in FY2023.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of -1.8%.
Declined from $0.41 to $0.13 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -18.1%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Sector benchmark
#52 of 192 in Health CareTop 27% of 192This company $0.13 Sector average $2.46
▼
-94.6% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 63.0% year-over-year.
- Ranks #52 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | -63.0% |
| FY2024 | $0.36 | -12.5% |
| FY2023 | $0.41 | +69.9% |
| FY2022 | $0.24 | +11.8% |
| FY2021 | $0.22 | +48.7% |
| FY2020 | $0.15 | +27.0% |
| FY2019 | $0.12 | -2.8% |
| FY2018 | $0.12 | +32.0% |
| FY2017 | $0.09 | -55.6% |
| FY2016 | $0.20 | +321.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026